Lind Asia and partners formed a joint venture to accelerate patient identification for multinational trials, leveraging a localized platform across Asia-Pacific countries.
1 report, 1 independent
Updated May 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lind Asia and partners formed a joint venture to accelerate patient identification for multinational trials, leveraging a localized platform across Asia-Pacific countries.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
American Society of Clinical Oncology
organization
Nothing else this week.